Certest Biotec, S.L.
Vanesa Tomás Zapatero has extensive experience in finance and administration. Vanesa began their career at Deloitte in 2007, where they worked as an Experience Senior I for four years. In 2011, they joined Grupo Olmeda as a Financial Controller for two years. Vanesa then moved on to El Corte Inglés, where they served as an Assistant to the Administrative Directorate from 2013 to 2015. After that, they joined Asseco Spain Group as the Chief Financial Officer, a position they held for four years. In 2019, they became the Chief Financial Officer at Certest Biotec, S.L., where they are currently employed.
Vanesa Tomás Zapatero has a diverse education history. Vanesa started in 1999 at the Facultad de Ciencias Económicas Zaragoza, where they pursued a degree in Licenciatura en Administración y Dirección de Empresas, focusing on Contabilidad y finanzas. Vanesa completed their undergraduate studies in 2004.
In 2004, Vanesa pursued further education at Centro Iniciativas Viables, where they obtained a degree as Técnico de comercio exterior, specializing in Comercio exterior.
In 2012, Vanesa enrolled at Escuela de Negocios de Caja de Ahorros de la Inmaculada, Zaragoza, to pursue a degree in Dirección Financiera. Vanesa completed this program in 2013.
Most recently, in 2019, Vanesa attended IE Business School, where they completed the Advanced Management Program, although the field of study is not specified.
This person is not in any teams
This person is not in any offices
Certest Biotec, S.L.
Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious diseases and different markers, covering different needs of formats, types of use, throughput, precision and time from sample to result. VIASURE offers a reliable molecular diagnostic solution, from sample to intepretation of results, covering a wide range portfolio of products and enabling laboratories to better inform clinical decissions. The objective of Certest Pharma is to contribute with its technology to obtain better therapeutic products based on RNA. It is focused on three main áreas: RNAs, Delivery and Vaccines. Additionally, the expertise of our highly qualified personnel, currently numbering over 300 employees, is at the disposal of our customers, offering development and manufacturing services for the production of their own materials.